Latest Asx News

3D Energi has confirmed a natural gas discovery at the Essington-1 well in the offshore Otway Basin, supported by direct gas sampling and preliminary analysis. Further testing is planned to assess the commercial potential of the find.

HomeCo Daily Needs REIT has announced a quarterly cash distribution of 2.15 cents per unit for Q3 2025, including a fund payment component under Australian tax law. The REIT confirms its tax structure intentions for the 2026 financial year.

Close the Loop Limited reports stronger Q1 FY26 revenue and EBITDA, boosted by strategic asset sales and operational improvements, while navigating key board and CFO departures.

Spacetalk Ltd reveals a successful pivot to a software-led, hardware-enabled model, reporting 12% revenue growth and expanding into 15 international markets. The company targets $20–25 million in recurring revenue for 2026, underpinned by new product launches and strategic telco partnerships.

Renegade Exploration has identified the Myschka prospect in Canada’s Yukon as a promising Reduced Intrusion-Related Gold System, with plans underway for maiden drilling in 2026. High-grade silver, gold, and antimony samples reinforce its potential within the prolific Tombstone Gold Belt.

Emyria Limited is fast-tracking its national rollout of Empax mental health clinics, backed by a strong $8 million institutional placement and new dual-payer funding pathways.

HITIQ Limited has launched its PROTEQT™ concussion management system in North America, securing exclusive Canadian distribution rights and initiating a dual-channel market strategy targeting hockey’s vast ecosystem.

Cyprium Metals has secured board approval to restart copper cathode production at its Nifty Copper Complex, targeting first output by mid-2026. The plan leverages existing heap leach resources and refurbishes key processing infrastructure to generate near-term cash flow.

Acorn Capital Investment Fund Limited (ACQ) reported a strong FY25 performance with a 15.1% net return and declared 5.5 cents per share in dividends, reinforcing its position in the Australian microcap sector.

Amplia Therapeutics has secured positive feedback from the US FDA on its Phase 2b/3 trial design for narmafotinib in pancreatic cancer, paving the way for a late 2026 trial start.

Perpetual Resources has identified a new lithium-bearing pegmatite trend exceeding 400 metres at its Mauricio Target in Brazil’s Lithium Valley, reinforcing the potential for multiple mineralised bodies within its Igrejinha Project. The company is intensifying exploration activities ahead of planned drilling in 2026.

Abacus Group reported a solid FY25 with modest growth in funds from operations and stable distributions, underpinned by strong leasing activity and a diversified commercial portfolio. The Group also highlighted significant progress in sustainability and reaffirmed its FY26 guidance amid improving market conditions.